Stock PLUR PLURI INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Pluri Inc.

Equities

PLUR

US72942G2030

Market Closed - Nasdaq
Other stock markets
 21:30:00 03/05/2024 BST 		5-day change 1st Jan Change
5.75 USD +1.95% Intraday chart for Pluri Inc. +7.34% +24.03%
05-02 Pluri Inc. Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment CI
05-02 Pluri Inc. Announces Appointments to Its Scientific Advisory Board CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alliance Global Lowers Pluristem Therapeutics' Price Target to $4 From $9.50, Maintains Buy Rating
MT
PLURISTEM THERAPEUTICS : Alliance Global Starts Pluristem Therapeutics at Buy with $12.50 Price Target
MT
PLURISTEM THERAPEUTICS : Jefferies Downgrades Pluristem Therapeutics to Hold From Buy; Adjusts PT $6 From $16
MT
PLURISTEM THERAPEUTICS : HC Wainwright Adjusts Pluristem Therapeutics' Price Target to $9 From $15.50, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PLUR Stock
  4. News Pluri Inc.
  5. Analyst Reco.